Related Experiment Video

Updated: Jul 11, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.5K

Systemic anticoagulation in ECMO

Shannon M Larabee1, Laura E Hollinger2, Adam M Vogel1

  • 1Texas Children's Hospital and Baylor College of Medicine, United States.

Seminars in Pediatric Surgery
|November 15, 2023
PubMed

Insights

Unfractionated heparin (UFH) and direct thrombin inhibitors (DTIs) are key anticoagulants for pediatric extracorporeal life support (ECMO). This review details their use, monitoring, and guidelines, noting a lack of consensus for pediatric ECMO anticoagulation.

Area of Science:

  • Pediatric critical care medicine
  • Hematology
  • Cardiovascular surgery

Background:

  • Unfractionated heparin (UFH) is the standard anticoagulant for pediatric extracorporeal life support (ECMO).
  • Direct thrombin inhibitors (DTIs) are increasingly utilized as alternatives or adjuncts.
  • Optimal anticoagulation management in pediatric ECMO remains challenging due to limited evidence and evolving practices.

Purpose of the Study:

  • To review current evidence on the utilization of UFH and DTIs in pediatric ECMO.
  • To compare the advantages and disadvantages of UFH and DTIs.
  • To outline anticoagulation monitoring strategies and recent guidelines for pediatric ECMO.

Main Methods:

  • Literature review of recent evidence regarding UFH and DTI use in pediatric ECMO.
  • Comparison of anticoagulant properties, efficacy, and safety profiles.
  • Analysis of Extracorporeal Life Support Organization (ELSO) guidelines and common clinical practices.

Main Results:

  • UFH and DTIs offer different benefits and risks in pediatric ECMO.
  • Effective anticoagulation monitoring is crucial for patient safety.
  • Current guidelines provide a framework, but consensus on pediatric ECMO anticoagulation is lacking.

Conclusions:

  • Evidence-based review of UFH and DTI use supports informed clinical decision-making in pediatric ECMO.
  • Tailored anticoagulation strategies, considering patient-specific factors and procedural risks, are essential.
  • Further research is needed to establish definitive consensus recommendations for pediatric ECMO anticoagulation.

Keywords:
Activated clotting timeActivated partial thromboplastin timeAnti-XaAnticoagulationDilute thrombin timeExtracorporeal membrane oxygenationHeparin, Direct thrombin inhibitorsViscoelastic assays

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

317
In Vitro Thrombosis Test for Ventricular Assist Devices09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

639

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
719
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
15
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
12